Dottorato in Medicina Molecolare

“CSPG4: a prototype oncoantigen for translational immunotherapy studies” Rolih V*, Barutello G*, Iussich S, De Maria R, Quaglino E, Buracco P, Cavallo F* and Riccardo F*. BioMed Research International 2016 (Submitted) * The first two authors contributed equally to this work

“Protection of mice against the highly pathogenic VVIHD-J by DNA and fowlpox recombinant vaccines, administered by electroporation and intranasal routes, correlates with serum neutralizing activity”  Bissa M, Quaglino E, Zanotto C, Illiano E, Rolih V, Pacchioni S, Cavallo F, De Giuli Morghen C and Radaelli A. Antiviral Research 2016 (Accepted)

“Prolongation of survival of dogs with oral malignant melanoma treated by en bloc surgical resection and adjuvant CSPG4-antigen electrovaccination.” Piras LA, Riccardo F, Iussich S, Maniscalco L, Gattino F, Martano M, Morello E, Lorda Mayayo S, Rolih V, Garavaglia F, De Maria R, Lardone E, Collivignarelli F, Mignacca D, Giacobino D, Ferrone S, Cavallo F, Buracco P. Vet Comp Oncol. 2016 May 4. doi: 10.1111/vco.12239

"Bovine herpesvirus 4-based vector delivering a hybrid rat/human HER-2 oncoantigen efficiently protects mice from autochthonous Her-2 + mammary cancer". Jacca S*, Rolih V*, Quaglino E*, Franceschi V, Tebaldi G, Bolli E, Rosamilia A, Ottonello S,  Cavallo F and Donofrio G. OncoImmunology  08/2015; DOI: 10.1080/2162402X.2015.1082705. * The first three authors contributed equally to this work.

Abstract e poster. “Bovine herpesvirus 4-based vectors encoding for chimeric HER2 antigen is effective in inducing a potent anti-tumor response against HER2+ mammary cancer” Rolih V, Jacca S, Franceschi V, Bolli E, Ballatore A, Merighi IF, Donofrio G, Cavallo F and Quaglino E. May 2016 Abano Terme (PD)  “X National Congress of SIICA”

"ErbB2⁺ breast cancer immunotherapy: pre-clinical data of new vaccine based on BoHV-4 viral vector"  Rolih V, Franceschi V, Jacca S, Bolli E, Donofrio G, Cavallo F and Quaglino E. June 2015 Candiolo, 2015 International conference on molecular oncology "From signal transduction to cancer precision medicine".

“Animal models for translational cancer immunotherapy studies”. Riccardo F, Rolih V, Cavallo F. September 2015 Portoroz, 1^st World Congress on Electroporation and Pulsed Electric Fields in biology, medicine, and food & environmental Technologies. International Federation for Medical and Biological Engineering. 

“BoHV-4 viral vector as a new approach for ErbB2⁺ breast cancer immunotherapy”. Rolih V, Franceschi V, Jacca S, Bolli E, Donofrio G, Cavallo F and Quaglino E. Maggio 2015 Mainz, CIMT Annual Meeting “The right patient for the right therapy”.

May 2016 Abano Terme (PD)  “X National Congress of SIICA”

June 2015 Candiolo IRCC, 2015 International conference on molecular oncology "From signal transduction to cancer precision medicine".

May 2015 Mainz, CIMT Annual Meeting “The right patient for the right therapy”.

February 2015 Turin, “Frontiers in regenerative medicine”. University of Turin.

September, 22^nd 2016 First Piedmont Bioinformatics Day. Organized by University of Turin in collaboration with Molecular Biotechnology Center.

May 24^th 2016 Turin, “Giornata di studio Guido Tarone”. Organized by Dottorato in Scienze Biomediche e Oncologia and Dottorato in Medicina Molecolare in collaboration with Molecular Biotechnology Center and Turin University.

April 11^th 2016 Turin “Sanità: la nuova sfida per la Torino dell’innovazione e della ricerca”. Organized by Fondazione Ricerca Molinette Onlus.

 March 8-9^th 2016 Turin, “Enabling technologies in 3D cancer organoids”. Turin University in collaboration with Politecnico of Turin.

October 2015, Turin University. Valorizzare le competenze dei dottori di ricerca e accompagnarli nel mondo del lvaoro.

September 2015 Turin University. D-Day

July 2015 Rozzano Centro congressi Humanitas, Flow cytometry in translational cancer research believe in rare!

February 2014. “Il trasferimento di conoscenza in ateneo: dalla ricerca alla valorizzazione dell’innovazione”. Scuola di Dottorato in Scienza della Vita e della Salute.

January 2015 “The biology of shape: from Aristotle to stem cells”. Prof. Stefano Piccolo. Scuola di Dottorato in Scienza della Vita e della Salute, corso Medicina Molecolare.

December 2014. “T cell & autoimmunity afternoon”. Aula CeRMS, AUO Città della Salute e della Scienza. Dottorato di Ricerca Medicina Molecolare, Università degli Studi di Torino.

October 2014. “Sperimentazione animale e metodi alternativi: tra miti, polemiche e realtà scientifica”. Fondazione Fondo Ricerca e Talenti.